In tumor lesions, the local expression of CCL5 and CXCL10 was positively associated with the expression of the CD8+ T lymphocyte markers CD8 and Granzyme B (RCD8 = 0.2338, pCD8 < 0.01, RGranB = 0.5517, pGranB < 0.001; RCD8 = 0.2972, pCD8 < 0.005, RGranB = 0.3204, pGranB < 0.001) (Figure 3). The gene discussed is CD8A; the disease is neoplasm.